- REFILE-UPDATE 1-Novavax buys manufacturing plant for $167 mln to boost COVID-19 vaccine production
Novavax Inc said on Wednesday it
would acquire a manufacturing plant in the Czech Republic for
$167 million as the drug developer looks to boost capacity to
produce its COVID-19 vaccine candidate.
Novavax, one of the handful of companies aiming to develop a
vaccine for COVID-19, said on Monday that it enrolled its first
participant in an early stage study testing the vaccine
candidate in humans.
- Novavax buys Praha Vaccines for $167 mln to boost COVID-19 vaccine production
Drug developer Novavax Inc on
Wednesday acquired Praha Vaccines, a unit of India's Cyrus
Poonawalla Group, for about $167 million as it looks to boost
capacity to produce its COVID-19 vaccine candidate.
The acquisition includes a biologics manufacturing facility
in Czech Republic, the company said, adding that the facility is
expected to provide an annual capacity of over 1 billion doses
of antigen starting in 2021 for its COVID-19 vaccine candidate,
- CEE MARKETS-FX move sideways, Czech bond sales ease
Central Europe's currencies tread
water on Wednesday as investors weighed the economic impact of
the coronavirus outbreak amid doubts over the effectiveness of a
potential vaccine, while the Czech Republic eased its barrage on
With countries in the region gradually emerging from
months-long lockdowns, investors are expected to get a clearer
picture of the overall hit to the economy in the coming period.
Poland, which began lockdown down measu
For more information about current affairs, business, economy, politics and more, use InsideWorld's free daily e-mail news service.
If you would like to receive news, but do not have an InsideWorld account yet, click below to setup your free account now and start receiving news right away.
|Click here for your free subscription
Login to your account for
for advanced settings:
is a collection of country and region web sites providing local news and information to a worldwide audience.
Use InsideWorld’s headlines available on this site to access the latest stories. Or sign up today.